Features
A DROP A DAY TO KEEP MYOPIA AT BAY
Clinical recommendations for the use of ophthalmic atropine for myopia control in 2024.
By ROHAN P.J. HUGHES, PHD, MOPTOM, BVISSC, EMILY C. WOODMAN-PIETERSE, PHD, BAPPSC(OPTOM)(HONS), BAPPSC(MED SC), GRADCERT(OCTHER), GRADCERT(ACADPRAC)
ADVANCED ORTHO-K PROBLEM-SOLVING
Fitting more “difficult” orthokeratology cases can result in happy and loyal patients.
By Roxanna Potter, OD
Web Exclusives
POINT/COUNTERPOINT: MYOPIA MANAGEMENT
A discussion about available myopia treatment options and which could be ideal in eight unique cases.
By RACHEL FENTON, OD, MS, JEFFREY J. WALLINE, OD, PHD, FAAO
AMNIOTIC MEMBRANE FOR DRY EYE
An exploration of how the use of amniotic membrane in patients with nonhealing epithelial defects improves patient comfort, vision, and more.
By Robert L. Davis, OD, FAAO, MOSHE SCHWARTZ, OD
REBOUND
A brief review of what studies are saying about rebound.
By Mark A. Bullimore, MCOptom, PhD, FAAO
AN INTERVIEW WITH JEREMY GUGGENHEIM, PHD, PQE (OPTOMETRY), BSC
Drs. Jeremy Guggenheim and Mark Bullimore dive into the genetics of myopia.
By Mark A. Bullimore, MCOptom, PhD, FAAO
OUR ORTHOKERATOLOGY TOOLBOX
Valuable tools to support myopia management decisions and treatment efficacy
By BROOKE MESSER, OD, FAAO, FSLS
Departments
ONLINE PHOTO
By DANIEL DELIGIO, OD
IS THIS THE NEW NORM?
Are Remote Scribes the New Norm?
By Mile Brujic, OD, FAAO, DAVID L. KADING, OD, FAAO
CONTACT LENS CASE REPORTS
Improving the VA of a Keratoconus Patient
By Gregory W. DeNaeyer, OD, FAAO